HEREDITARY PANCREATIC CANCER: CLINICAL EXOME PANEL (Sec. & CNVs) – 35 genes
LabGenetics
Delivery time
3-4 weeks
Sample
Blood
The Hereditary Pancreatic Cancer Panel studies the genes responsible for familial predisposition to pancreatic ductal adenocarcinoma and other pancreatic tumors associated with genetic syndromes. It includes key genes involved in DNA repair, cell cycle control, and tumor signaling, such as BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, STK11, TP53, and SMAD4. This panel allows for the identification of alterations present in hereditary pancreatic cancer predisposition syndromes, such as Peutz-Jeghers syndrome (STK11), Lynch syndrome, Li-Fraumeni syndrome (TP53), and BRCA1/2 syndrome, among others. Its clinical application is essential for familial risk stratification, early screening, and the selection of personalized treatments, such as the use of PARP inhibitors or platinum-based chemotherapy. Genes analyzed: BRCA1, BRCA2, PALB2, ATM, STK11, TP53, MLH1, MSH2, SMAD4, CHEK2, and others. You can consult the complete list of genes analyzed by contacting Genotica.
Other tests
Preventive health test - AboutMe EXOME
545,00€
NEUROFIBROMATOSIS: GENES SMARCB1 Y LZTR1 (NGS-Sec) – ATG Medical
600,00€
Custom sequencing panels (1 to 15 genes)
660,00€